Richard Godfrey joined BerGenBio as Chief Executive Officer in 2008. He has more than 25 years' industry experience leading many international drug development and commercialisation partnerships.
— Sachs Associates (@SachsAssociates) July 23, 2020
e-Meet Richard at #Sachs_BEF
More info @ https://t.co/XI3zEYGyl2 pic.twitter.com/W5SPRdeMfT